Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Gobbi

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Psychopharmacology|December 27, 2011
The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiologyStefano Comai, Michael Tau, Gabriella Gobbi
Journal of Child Psychology and Psychiatry, and Allied Disciplines|May 6, 2017
Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorderTobias Atkin, Nicolas Nuñez, Gabriella Gobbi
Neuropsychiatric Disease and Treatment|May 24, 2014
Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative studyGabriella Gobbi, Stefano Comai, Guy Debonnel
Behavioural Brain Research|January 22, 2013
Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout miceStefano Comai, Rafael Ochoa-Sanchez, Gabriella Gobbi
Reviews in the Neurosciences|October 24, 2012
Characterization of serotonin neurotransmission in knockout mice: implications for major depressionSergio Domínguez-López, Rebecca Howell, Gabriella Gobbi
Journal of Clinical Psychopharmacology|September 16, 2006
Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosisGabriella Gobbi, Pierre-Olivier Gaudreau, Nancy Leblanc
Pharmacological Reviews|December 17, 2020
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter MechanismsAntonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Trends in Pharmacological Sciences|October 25, 2008
Brain TRPV1: a depressing TR(i)P down memory lane?Vincenzo Di Marzo, Gabriella Gobbi, Arpad Szallasi
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 4, 2009
Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortexBenoit Labonte, Francis Rodriguez Bambico, Gabriella Gobbi
The Journal of Clinical Psychiatry|February 4, 2003
Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1)Luca Santarelli, Gabriella Gobbi, Pierre Blier, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Psychopharmacology|December 27, 2011
The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiologyStefano Comai, Michael Tau, Gabriella Gobbi
Journal of Child Psychology and Psychiatry, and Allied Disciplines|May 6, 2017
Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorderTobias Atkin, Nicolas Nuñez, Gabriella Gobbi
Neuropsychiatric Disease and Treatment|May 24, 2014
Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative studyGabriella Gobbi, Stefano Comai, Guy Debonnel
Behavioural Brain Research|January 22, 2013
Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout miceStefano Comai, Rafael Ochoa-Sanchez, Gabriella Gobbi
Reviews in the Neurosciences|October 24, 2012
Characterization of serotonin neurotransmission in knockout mice: implications for major depressionSergio Domínguez-López, Rebecca Howell, Gabriella Gobbi
Journal of Clinical Psychopharmacology|September 16, 2006
Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosisGabriella Gobbi, Pierre-Olivier Gaudreau, Nancy Leblanc
Pharmacological Reviews|December 17, 2020
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter MechanismsAntonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Trends in Pharmacological Sciences|October 25, 2008
Brain TRPV1: a depressing TR(i)P down memory lane?Vincenzo Di Marzo, Gabriella Gobbi, Arpad Szallasi
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 4, 2009
Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortexBenoit Labonte, Francis Rodriguez Bambico, Gabriella Gobbi
The Journal of Clinical Psychiatry|February 4, 2003
Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1)Luca Santarelli, Gabriella Gobbi, Pierre Blier, et al.
Pageof 12